Discovery in human acute myeloid leukemia could provide novel pathway to new treatments

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Researchers at Mount Sinai have discovered that human acute myeloid leukemia (AML) stem cells are dependent on a transcription factor known as RUNX1, potentially providing a new therapeutic target to achieve lasting remissions or even cures for a disease in which medical advances have been limited.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news